RenalSense

RenalSense is a medical device company based in Jerusalem, Israel, founded in 2009. The company specializes in real-time renal diagnostics, focusing on improving critical care through accurate and continuous monitoring of kidney function, particularly in intensive care units (ICUs) and hospital environments. The flagship product, Clarity RMS (Renal Monitoring System), automatically tracks urine flow in real time. This system enables early detection of changes in renal function and the risk of Acute Kidney Injury (AKI), while also monitoring treatment effectiveness. By providing healthcare providers with timely data on renal function alongside other vital signs, Clarity RMS aims to enhance patient outcomes. RenalSense has established a global marketing network, reaching regions such as Europe, North America, China, Israel, and Taiwan. The company is committed to advancing its product line and expanding its presence in medical centers worldwide.

• Employees 9
• Founded 2010
• Total Funding $14828270